Radiotherapy Combined Chimeric Antigen Receptor T-Cells Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma(R/R DLBCL)

被引：0
|
作者：
Zhou, Lili [1 ]
Liu, Yifan [1 ]
Ye, Shiguang [1 ]
Li, Ping [1 ]
Li, Shaoguang [2 ]
Liang, Aibin [1 ]
机构：
[1] Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai, Peoples R China
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184352
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)
    Bachanova, Veronika
    Tam, Constantine S.
    Borchmann, Peter
    Jaeger, Ulrich
    McGuirk, Joseph P.
    Holte, Harald
    Waller, Edmund K.
    Jaglowski, Samantha
    Bishop, Michael R.
    Andreadis, Charalambos
    Foley, Stephen Ronan
    Westin, Jason R.
    Fleury, Isabelle
    Ho, P. Joy
    Mielke, Stephan
    Teshima, Takanori
    Salles, Gilles
    Schuster, Stephen J.
    Maziarz, Richard T.
    Van Besien, Koen
    Izutsu, Koji
    Kersten, Marie Jose
    Magenau, John M.
    Wagner-Johnston, Nina D.
    Kato, Koji
    Corradini, Paolo
    Chu, Jufen
    Gershgorin, Irina
    Choquette, Therese
    Pacaud, Lida Bubuteishvili
    Jeschke, Margit
    BLOOD, 2019, 134
  • [2] Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Combined with Zanubrutinib in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Wang, Langqi
    Yang, Jilong
    Jin, Bo
    Wang, Bo
    Zhou, Lijuan
    Zhuo, Yaqi
    Chen, Huifang
    Chang, Lung-Ji
    Tu, Sanfang
    Li, Yuhua
    BLOOD, 2023, 142
  • [3] Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Gatwood, Justin
    Masaquel, Anthony
    Ross, Ryan
    Sheinson, Danny
    Hossain, Farah
    Li, Jia
    James, Cameron
    Fox, David
    BLOOD, 2022, 140 : 7906 - 7907
  • [4] Therapeutic effects of chimeric antigen receptor T cells (CAR-T) on relapse/refractory diffuse large B-cell lymphoma (R/R DLBCL): a meta-analysis
    Cao, H-H
    Wang, L-L
    Geng, C-K
    Mao, W-W
    Yang, L-L
    Ma, Y.
    He, M.
    Zhang, R.
    Zhou, Y-Y
    Liu, L-Q
    Hu, X-J
    Yu, J-X
    Yang, L.
    Shen, X-F
    Yin, L-F
    Gu, X-Z
    Shen, Z-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (09) : 4921 - 4930
  • [5] Efficacy and safety of chimeric antigen receptor T cell therapy combined with zanubrutinib in the treatment of relapsed/refractory diffuse large B-cell lymphoma
    Wang, Langqi
    Yue, Chunyan
    Zhou, Xuan
    Yang, Jilong
    Jin, Bo
    Wang, Bo
    Huang, Minhong
    Chen, Huifang
    Zhou, Lijuan
    Tu, Sanfang
    Li, Yuhua
    CHINESE MEDICAL JOURNAL, 2025, 138 (06) : 748 - 750
  • [6] Real-world outcomes of elderly patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor T-cell (CAR-T) therapy.
    Fitzgerald, Lindsey
    Kittai, Adam
    Nastoupil, Loretta J.
    Waller, Alexandra
    Jacobson, Caron A.
    Saucier, Anna
    Kamdar, Manali K.
    Spradley, Janet
    Denlinger, Nathan
    Chipman, Jonathan
    Hu, Boyu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma
    Ernst, Moritz
    Oeser, Annika
    Besiroglu, Burcu
    Caro-Valenzuela, Julia
    Aziz, Mohamed Abd El
    Monsef, Ina
    Borchmann, Peter
    Estcourt, Lise J.
    Skoetz, Nicole
    Goldkuhle, Marius
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
  • [8] Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Dyer, Martin J. S.
    De Vos, Sven
    Ruan, Jia
    Flowers, Christopher
    Maddocks, Kami J.
    Rule, Simon
    Hamdy, Ahmed M.
    Izumi, Raquel
    Slatter, J. Greg
    Cheung, Jean
    Frigualt, Melanie M.
    Wei, Helen
    Mourya, Sanchita
    Hunder, Naomi N. H.
    Fowler, Nathan Hale
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report
    Chen, Hsin-Hui
    Kuo, Cheng-Yi
    Ho, Ching-Liang
    Chen, Yeu-Chin
    MEDICINE, 2023, 102 (41) : E35432
  • [10] Understanding the patient experience in follicular lymphoma (FL), relapsed/refractory FL (R/R FL), and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
    Bell, Jill A.
    Cherepanov, Dasha
    Revicki, Dennis
    Speck, Rebecca M.
    Swett, Laura
    Stumpo, Kate
    Rong, Yuanxin
    Gordon, Leo I.
    QUALITY OF LIFE RESEARCH, 2019, 28 : S67 - S68
12345